These findings strongly suggested that IGFBP-3 may exert anti-proliferative and anti-tumor functions beyond its ability to modulate IGF functions (IGF/IGF-IR dependent actions), but the underlying mechanisms involved remain largely unknown. The gene discussed is IGF1R; the disease is neoplasm.